|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.6 SEK | -6.86% |
|
-3.73% | +13.03% |
| 05-29 | Integrum Receives Market Approval for Opra®? Implant System in Israel | CI |
| 05-15 | Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu | CI |
Integrum (publ) announced that the company has appointed Annika Fahlén as Director of Quality Assurance and Regulatory Affairs, QARA. Annika Fahlén will join the company on 1 April 2023 and will be part of the management team. Annika Fahlén has vast experience in the field of Quality Assurance and Regulatory Affairs working at Mölnlycke, Getinge, Qing and Abigo.
She will join Integrum from a position as Regulatory Affairs Quality Assurance Director at Essity.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.03% | 95.86M | |
| +3.97% | 18.81B | |
| +7.11% | 13.64B | |
| +10.14% | 10.29B | |
| -17.47% | 2.05B | |
| +2.37% | 1.72B | |
| +11.05% | 1.37B | |
| +10.93% | 564M | |
| 0.00% | 405M | |
| +63.22% | 199M |
INTEGRUM AB 
